Terns Pharmaceuticals, Inc. (NASDAQ: TERN) Stock Information | RedChip

Terns Pharmaceuticals, Inc. (NASDAQ: TERN)


$5.0050
-0.2400 ( -2.06% ) 521.9K

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

Market Data


Open


$5.0050

Previous close


$5.2450

Volume


521.9K

Market cap


$425.97M

Day range


$4.9660 - $5.2550

52 week range


$4.3200 - $11.4000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
8-k 8K-related 11 Jun 12, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 04, 2024
8-k 8K-related 13 May 13, 2024

Latest News